Deutsche Bank Adjusts Price Target on IQVIA Holdings to $250 From $235, Maintains Buy Rating
AI Sentiment
Positive
7/10
as of 12-19-2025 3:38pm EST
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
| Founded: | 1982 | Country: | United States |
| Employees: | N/A | City: | DURHAM |
| Market Cap: | 36.4B | IPO Year: | 2013 |
| Target Price: | $237.59 | AVG Volume (30 days): | 1.4M |
| Analyst Decision: | Buy | Number of Analysts: | 17 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 7.30 | EPS Growth: | -4.16 |
| 52 Week Low/High: | $134.65 - $234.29 | Next Earning Date: | 02-05-2026 |
| Revenue: | $15,904,000,000 | Revenue Growth: | 3.85% |
| Revenue Growth (this year): | 6.14% | Revenue Growth (next year): | 5.35% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
See Remarks
Avg Cost/Share
$222.43
Shares
36,564
Total Value
$8,132,930.52
Owned After
820,599
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| BOUSBIB ARI | IQV | See Remarks | Dec 18, 2025 | Sell | $222.43 | 36,564 | $8,132,930.52 | 820,599 |
IQV Breaking Stock News: Dive into IQV Ticker-Specific Updates for Smart Investing
AI Sentiment
Positive
7/10
AI Sentiment
Neutral
5/10
AI Sentiment
Highly Positive
8/10
See how IQV stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "IQV IQVIA Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.